Hong Kong, China vs Niger: Treatment success rate for patients treated for MDR-TB
Hong Kong, China
72.0%
in 2022
Niger
72.0%
in 2022
Hong Kong, China rank
87th
Niger rank
87th
Treatment success rate for patients treated for MDR-TB over time
- Hong Kong, China
- Niger
How they compare
Hong Kong, China currently reports 72.0% against 72.0% in Niger, a difference of 0.0%.
The two have swapped places 4 times across 16 shared years of data; in 2007 it was Niger ahead.
Hong Kong, China ranks 87th and Niger ranks 87th of 163 countries.
Across the 3 decades both report, Hong Kong, China averaged higher in 1 and Niger in 2.
Head to head by decade
| Decade | Hong Kong, China | Niger | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 59.0% | 85.7% | 26.7% | Niger |
| 2010s | 70.8% | 83.5% | 12.7% | Niger |
| 2020s | 80.0% | 74.3% | 5.7% | Hong Kong, China |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Hong Kong, China or Niger?
- Hong Kong, China, at 72.0% against 72.0% in Niger as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Hong Kong, China and Niger?
- 0.0%, with Hong Kong, China ahead.
- How many years of comparable data are there for Hong Kong, China and Niger?
- 16 years are reported by both, from 2007 to 2022.
- How do Hong Kong, China and Niger rank globally for treatment success rate for patients treated for mdr-tb?
- Hong Kong, China ranks 87th and Niger ranks 87th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.